CompletedNot Applicable

Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial

United States50 participantsStarted 2023-10-20

Plain-language summary

The goal of this clinical trial in adults with obstructive sleep apnea prescribed positive airway pressure therapy is to test the effects of a new patient-facing consumer wearable-based program (that involves provision of a consumer wearable that measures oxygen levels during sleep plus customized weekly reports to participants). The main question is to learn whether participants' use of positive airway pressure therapy will differ between the participants who receive the new program immediately versus delayed. Participants assigned to the delayed program will receive usual care while waiting for the program to begin.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Prescribed PAP therapy from the sleep center for \> 1 week * Have an active profile in our Center's ResMed AirView or Respironics Care Orchestrator accounts for \> 1 week * Non-adherent with PAP therapy * Willing to continue using current PAP device for 28 days continuously * Have an electronic device compatible with the wearable app Exclusion Criteria: * Diagnosis of heart failure, chronic lung disease, dementia, active substance use disorder * Use home oxygen * Unstable medical or psychiatric illness * Planned non-use of PAP therapy (e.g., waiting for replacement of recalled PAP device) * Planned surgery or hospitalization during study period * Planned extensive travel during study period * History of repeated non-attendance at clinic visits

What they're measuring

PAP adherence (minutes)

Timeframe: 5 weeks

Trial details

NCT IDNCT06039865

SponsorVA Greater Los Angeles Healthcare System

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2025-01-21